Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Glynne-Jones

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Nature Clinical Practice. Oncology|October 15, 2008
Anal cancer: is neoadjuvant cisplatin chemotherapy or chemoradiotherapy friend or foe?Robert Glynne-Jones, Suzannah Mawdsley
Current Treatment Options in Oncology|March 21, 2022
The Evolving Neoadjuvant Treatment Paradigm for Patients with Locoregional mismatch Repair Proficient Rectal CancerJyotsna Bhudia, Robert Glynne-Jones
Cancers|May 13, 2023
Selecting a TNT Schedule in Locally Advanced Rectal Cancer: Can We Predict Who Actually Benefits?Carlo Aschele, Robert Glynne-Jones
Drugs|June 30, 2011
Locally advanced rectal cancer: a comparison of management strategiesRobert Glynne-Jones, Miranda Kronfli
The Lancet. Oncology|May 28, 2021
The concept and use of the neoadjuvant rectal score as a composite endpoint in rectal cancerRobert Glynne-Jones, Stuart Glynne-Jones
Gastrointestinal Cancer Research : GCR|April 9, 2009
Accomplishments in 2007 in the adjuvant treatment of rectal cancerLisa A Kachnic, Robert Glynne-Jones
Acta Oncologica (Stockholm, Sweden)|February 16, 2010
Could a wait and see policy be justified in T3/4 rectal cancers after chemo-radiotherapy?Robert Hughes, Mark Harrison, Robert Glynne-Jones
Cancer Treatment Reviews|July 5, 2024
Oncological risks associated with the planned watch-and-wait strategy using total neoadjuvant treatment for rectal cancer: A narrative reviewJoanna Socha, Robert Glynne-Jones, Krzysztof Bujko
Anti-Cancer Drugs|February 25, 2011
Antiepidermal growth factor receptor radiosensitizers in rectal cancerRobert Glynne-Jones, Suzy Mawdsley, Mark Harrison
Oncology (Williston Park, N.Y.)|August 21, 2014
Pelvic MRI for guiding treatment decisions in rectal cancerRobert Glynne-Jones, David Tan, Vicky Goh
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Nature Clinical Practice. Oncology|October 15, 2008
Anal cancer: is neoadjuvant cisplatin chemotherapy or chemoradiotherapy friend or foe?Robert Glynne-Jones, Suzannah Mawdsley
Current Treatment Options in Oncology|March 21, 2022
The Evolving Neoadjuvant Treatment Paradigm for Patients with Locoregional mismatch Repair Proficient Rectal CancerJyotsna Bhudia, Robert Glynne-Jones
Cancers|May 13, 2023
Selecting a TNT Schedule in Locally Advanced Rectal Cancer: Can We Predict Who Actually Benefits?Carlo Aschele, Robert Glynne-Jones
Drugs|June 30, 2011
Locally advanced rectal cancer: a comparison of management strategiesRobert Glynne-Jones, Miranda Kronfli
The Lancet. Oncology|May 28, 2021
The concept and use of the neoadjuvant rectal score as a composite endpoint in rectal cancerRobert Glynne-Jones, Stuart Glynne-Jones
Gastrointestinal Cancer Research : GCR|April 9, 2009
Accomplishments in 2007 in the adjuvant treatment of rectal cancerLisa A Kachnic, Robert Glynne-Jones
Acta Oncologica (Stockholm, Sweden)|February 16, 2010
Could a wait and see policy be justified in T3/4 rectal cancers after chemo-radiotherapy?Robert Hughes, Mark Harrison, Robert Glynne-Jones
Cancer Treatment Reviews|July 5, 2024
Oncological risks associated with the planned watch-and-wait strategy using total neoadjuvant treatment for rectal cancer: A narrative reviewJoanna Socha, Robert Glynne-Jones, Krzysztof Bujko
Anti-Cancer Drugs|February 25, 2011
Antiepidermal growth factor receptor radiosensitizers in rectal cancerRobert Glynne-Jones, Suzy Mawdsley, Mark Harrison
Oncology (Williston Park, N.Y.)|August 21, 2014
Pelvic MRI for guiding treatment decisions in rectal cancerRobert Glynne-Jones, David Tan, Vicky Goh
Pageof 5